ESERX
Price
$34.03
Change
-$0.40 (-1.16%)
Updated
Nov 13 closing price
Net Assets
593.38M
RGEBX
Price
$83.30
Change
-$1.87 (-2.20%)
Updated
Nov 13 closing price
Net Assets
340.4B
Interact to see
Advertisement

ESERX vs RGEBX

Header iconESERX vs RGEBX Comparison
Open Charts ESERX vs RGEBXBanner chart's image
Eaton Vance Atlanta Capital Sel Eq R6
Price$34.03
Change-$0.40 (-1.16%)
VolumeN/A
Net Assets593.38M
American Funds Growth Fund of Amer R2E
Price$83.30
Change-$1.87 (-2.20%)
VolumeN/A
Net Assets340.4B
ESERX vs RGEBX Comparison Chart in %
View a ticker or compare two or three
VS
ESERX vs. RGEBX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESERX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 340B vs. ESERX (593M). ESERX (0.00) and RGEBX (0.00) have matching dividends . ESERX was incepted earlier than RGEBX: ESERX (9 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than ESERX (0.75). RGEBX is a more actively managed with annual turnover of: 25.00 vs. ESERX (2.00). RGEBX has a lower initial minimum investment than ESERX: RGEBX (250) vs ESERX (5000000). RGEBX annual gain was more profitable for investors over the last year : 8.10 vs. ESERX (-11.19). RGEBX return over 5 years is better than : 36.65 vs. ESERX (13.37).
ESERXRGEBXESERX / RGEBX
Total Expense Ratio0.751.0969%
Annual Report Gross Expense Ratio0.751.0969%
Fund Existence9 years11 years-
Gain YTD-4.75819.219-25%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets593M340B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year-11.198.10-138%
Returns for 3 years18.6062.3930%
Returns for 5 years13.3736.6536%
Returns for 10 yearsN/A93.78-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRUG60.150.91
+1.54%
Bright Minds Biosciences
SRPT18.000.02
+0.11%
Sarepta Therapeutics
WSBCP24.98N/A
N/A
WesBanco
XP19.21-0.59
-2.98%
XP
HKIT2.37-0.39
-14.13%
Hitek Global